NCT03531853View on ClinicalTrials.gov

OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers

NACompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

March 10, 2021

Study Completion Date

March 10, 2021

Conditions

Uveitis

Interventions

DEVICE

hand-held swept source optical coherence tomography

images the eye

Trial Locations (1)

27705

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT03531853 - OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers | Biotech Hunter | Biotech Hunter